R

retatrutide

Product

by Eli Lilly and Company

Heard in 6 episodes across 6 shows since Aug 2026

An investigational once-weekly medication that activates GLP-1, GIP, and glucagon receptors and is being studied for obesity, diabetes, and related metabolic conditions.

Learn more
Discussed inHealth & Science100%

Episodes

6
across 6 shows

This week

0
episodes on 0 shows

Share of the conversation

Mentions of retatrutide per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.

0.0‰0.05‰0.1‰0.15‰Jul 11Aug 2Aug 25Sep 16Oct 8
Show the data
DayShare (7-day)Mentions
Aug 120.04‰1
Sep 10.03‰1
Sep 30.12‰3
Sep 80.14‰1
Sep 210.03‰1

The full trend: rank, tone and why it is trending →

Episodes

6 episodes featuring retatrutide, newest first

retatrutide · PodLume